NGM Bio Pinpoints Fourth Antibody Drug Candidate for Oncology Therapy Development August 25, 2021 Auto Bot News 0 NGM Biopharmaceuticals has disclosed a fourth antibody drug candidate, NGM831, for development into an oncology therapeutic.
